Imatinib 400 mg cap: Supply issue and brand change
In November 2020, we advised that the supplier, AFT, would go out of stock of its brand of imatinib mesilate cap 400 mg by the end of the year.
The out of stock is caused by delays in production at the manufacturing plant.
To ensure continuity of supply, PHARMAC listed the Rex brand imatinib 400 mg cap from 1 December 2020. Pharmacode 2594323.
Originally, the Rex brand was going to be listed in the Schedule on 1 January 2021.
The sole supply and delisting dates remain unchanged. Imatinib-Rex will be sole supply from 1 June 2021.
The imatinib 100 mg cap is not affected by this stock issue. The Rex brand was listed on 1 January 2021 as originally planned.
Both presentations of Imatinib-AFT will be delisted on 31 May 2020.